B
California Nanotechnologies Corp. CANOF
$0.294 $0.0145.00%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
B
Buy 3/28/2024Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to B- from C+ on 3/28/2024 due to a large increase in the total return index.
C
Hold 3/13/2024Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to C+ from B- on 3/13/2024 due to a large decline in the total return index.
B
Buy 2/27/2024Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to B- from C+ on 2/27/2024 due to a large increase in the total return index and volatility index.
C
Hold 2/9/2024Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to C+ from B- on 2/9/2024 due to a major decline in the total return index.
B
Buy 11/28/2023Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to B- from C on 11/28/2023 due to a significant increase in the valuation index, growth index and volatility index. Earnings per share increased from $0.001 to $0.0063, EBIT increased 272.64% from $64.7 to $241.1, and operating cash flow increased 127.29% from -$56.8 to $15.5.
C
Hold 9/26/2023Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to C from C+ on 9/26/2023 due to a decline in the valuation index, total return index and volatility index.
C
Hold 8/4/2023Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to C+ from C on 8/4/2023 due to a significant increase in the growth index and efficiency index. EBIT increased 661.18% from $8.5 to $64.7, net income increased 503.41% from -$8.8 to $35.5, and earnings per share increased from -$0.0003 to $0.001.
C
Hold 7/21/2023Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to C from C- on 7/21/2023 due to a major increase in the total return index and volatility index.
C
Hold 7/5/2023Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to C- from C on 7/5/2023 due to a large decline in the total return index.
C
Hold 6/30/2023Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to C from C+ on 6/30/2023 due to a significant decline in the growth index and valuation index. Earnings per share declined from $0.002 to -$0.0003, EBIT declined 91.85% from $104.3 to $8.5, and total revenue declined 13.38% from $418.4 to $362.4.
C
Hold 6/20/2023Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to C+ from C on 6/20/2023 due to an increase in the total return index.
C
Hold 6/2/2023Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to C from C+ on 6/2/2023 due to a large decline in the total return index, valuation index and volatility index.
C
Hold 5/17/2023Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to C+ from C on 5/17/2023 due to a large increase in the total return index and volatility index.
C
Hold 4/19/2023Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to C from C+ on 4/19/2023 due to a decline in the total return index and valuation index.
C
Hold 4/4/2023Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to C+ from C on 4/4/2023 due to an increase in the valuation index.
C
Hold 3/20/2023Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to C from C+ on 3/20/2023 due to a decline in the total return index.
C
Hold 3/3/2023Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to C+ from C on 3/3/2023 due to a major increase in the total return index and volatility index.
C
Hold 2/16/2023Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to C from C+ on 2/16/2023 due to a decline in the total return index.
C
Hold 2/1/2023Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to C+ from C- on 2/1/2023 due to a significant increase in the growth index, solvency index and volatility index. EBIT increased 1,309.46% from $7.4 to $104.3, earnings per share increased from -$0.0008 to $0.002, and total revenue increased 53.82% from $272 to $418.4.
C
Hold 11/2/2022Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to C- from C on 11/2/2022 due to a significant decline in the growth index, efficiency index and total return index. Net income declined 152.68% from $50.3 to -$26.5, earnings per share declined from $0.0016 to -$0.0008, and EBIT declined 89.29% from $69.1 to $7.4.
C
Hold 10/24/2022Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to C from C+ on 10/24/2022 due to a substantial decline in the total return index.
C
Hold 10/7/2022Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to C+ from C on 10/7/2022 due to a substantial increase in the total return index and valuation index.
C
Hold 9/22/2022Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to C from C+ on 9/22/2022 due to a noticeable decline in the total return index.
C
Hold 9/6/2022Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to C+ from C on 9/6/2022 due to a significant increase in the total return index, efficiency index and solvency index. The quick ratio increased from 0.23 to 1.31, total capital increased 26.7% from $623.6 to $790.1, and debt to equity declined from -1.35 to -1.54.
C
Hold 6/29/2022Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to C from D on 6/29/2022 due to a significant increase in the valuation index, growth index and efficiency index. EBIT increased 3,246.58% from -$7.3 to $229.7, operating cash flow increased 2,381.13% from $5.3 to $131.5, and earnings per share increased from -$0.0006 to $0.0082.
D
Sell 5/5/2022Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to D from D- on 05/05/2022.
D
Sell 4/20/2022Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to D- from D on 4/20/2022 due to a significant decline in the total return index.
D
Sell 11/23/2021Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
D
Sell 11/8/2021Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to D- from D on 11/8/2021 due to a major decline in the growth index and volatility index. EBIT declined 418.03% from $6.1 to -$19.4, earnings per share declined from -$0.0003 to -$0.0007, and total revenue declined 18.51% from $206.4 to $168.2.
D
Sell 7/30/2021Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to D from D+ on 7/30/2021 due to a large decline in the total return index, valuation index and volatility index.
D
Sell 3/15/2021Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to D+ from D on 3/15/2021 due to an increase in the total return index, volatility index and valuation index.
D
Sell 2/16/2021Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to D from D+ on 2/16/2021 due to a decline in the valuation index.
D
Sell 2/1/2021Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to D+ from D on 2/1/2021 due to an increase in the total return index and volatility index.
D
Sell 1/8/2021Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to D from D+ on 1/8/2021 due to a decline in the volatility index and solvency index. Debt to equity increased from -1.37 to -0.26, and the quick ratio declined from 0.05 to 0.05.
D
Sell 12/31/2020Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to D+ from D on 12/31/2020 due to a significant increase in the total return index, volatility index and valuation index.
D
Sell 11/25/2019Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to D from D+ on 11/25/2019 due to a noticeable decline in the efficiency index, growth index and total return index.
D
Sell 11/5/2019Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to D+ from D on 11/5/2019 due to a significant increase in the growth index, efficiency index and solvency index. Operating cash flow increased 2,177.78% from -$2.7 to $56.1, EBIT increased 256.91% from -$55 to $86.3, and earnings per share increased from -$0.0022 to $0.0021.
D
Sell 7/5/2019Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to D from C on 7/5/2019 due to a significant decline in the growth index, efficiency index and valuation index. Earnings per share declined from $0.001 to -$0.0017, net income declined 265.71% from $31.5 to -$52.2, and EBIT declined 164.96% from $48.8 to -$31.7.
C
Hold 6/19/2019Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to C from C- on 6/19/2019 due to an increase in the total return index.
C
Hold 6/4/2019Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to C- from C on 6/4/2019 due to a decline in the total return index.
C
Hold 5/8/2019Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to C from C- on 5/8/2019 due to an increase in the total return index.
C
Hold 5/7/2019Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to C- from D+ on 5/7/2019 due to a large increase in the valuation index, total return index and volatility index.
D
Sell 4/18/2019Downgrade
California Nanotechnologies Corp. (CANOF) was downgraded to D+ from C- on 4/18/2019 due to a decline in the volatility index, valuation index and total return index.
C
Hold 3/14/2019Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to C- from D+ on 3/14/2019 due to an increase in the volatility index and total return index.
D
Sell 12/14/2018Upgraded
California Nanotechnologies Corp. (CANOF) was upgraded to D+ from D on 12/14/2018 due to a significant increase in the valuation index, efficiency index and growth index. EBIT increased 759.46% from -$7.4 to $48.8, net income increased 232.35% from -$23.8 to $31.5, and earnings per share increased from -$0.001 to $0.001.
D
Sell 7/16/2018Downgrade
California Nanotechnologies Corp (CANOF) was downgraded to D from D+ on 7/16/2018 due to a large decline in the efficiency index and volatility index.
D
Sell 6/29/2018Upgraded
California Nanotechnologies Corp (CANOF) was upgraded to D+ from D- on 6/29/2018 due to a substantial increase in the growth index and efficiency index. EBIT increased 1,156.25% from $3.2 to $40.2, earnings per share increased from -$0.0012 to $0.0016, and net income increased 232.71% from -$37.3 to $49.5.
D
Sell 1/5/2018Downgrade
California Nanotechnologies Corp (CANOF) was downgraded to D- from D on 1/5/2018 due to a major decline in the growth index, volatility index and solvency index. Earnings per share declined from $0.0004 to -$0.01, the quick ratio declined from 0.07 to 0.04, and EBIT declined 33.97% from -$47.1 to -$63.1.
D
Sell 11/29/2016Upgraded
California Nanotechnologies Corp (CANOF) was upgraded to D from D- on 11/29/2016 due to an increase in the volatility index, total return index and efficiency index. Net income increased 65.14% from -$69.7 to -$24.3, and total capital increased 6.59% from $107.7 to $114.8.
D
Sell 3/1/2016Upgraded
California Nanotechnologies Corp (CANOF) was upgraded to D- from E+ on 3/1/2016 due to a significant increase in the growth index. Total revenue increased 58.32% from $90.7 to $143.6.
E
Sell 12/1/2015Upgraded
California Nanotechnologies Corp (CANOF) was upgraded to E+ from E on 12/1/2015 due to a major increase in the total return index, volatility index and efficiency index.
E
Sell 9/15/2015Upgraded
California Nanotechnologies Corp (CANOF) was upgraded to E from on 9/15/2015 due to a significant increase in the solvency index, volatility index and growth index. Earnings per share increased from -$0.0039 to -$0.01, total revenue increased 80.94% from $53 to $95.9, and debt to equity declined from -1.42 to -1.31.
Weiss Ratings